What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. (Q34245541)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6 references

3 April 2019

25 June 2019

19 September 2019

20 September 2020

8 February 2021

27 June 2021

What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

adaptive radiation therapy

1 reference

20 September 2020

1 reference

3 April 2019

biomedical investigative technique

1 reference

19 September 2019

1 reference

8 February 2021

cost–benefit analysis

1 reference

27 June 2021

Hasan Başarır

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

M Barbieri

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

H L A Weatherly

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

R Ara

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Sculpher

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

H Ahmed

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C Coles

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

T Guerrero-Urbano

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C Nutting

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Powell

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

1 October 2014

7 references

Europe PubMed Central

PubMed publication ID

31 July 2017

3 April 2019

25 June 2019

19 September 2019

20 September 2020

8 February 2021

27 June 2021

full work available at URL

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175431

0 references

Applied Health Economics and Health Policy

7 references

3 April 2019

25 June 2019

19 September 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

20 September 2020

8 February 2021

27 June 2021

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

497-510

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

25 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Mapping to obtain EQ-5D utility values for use in NICE health technology assessments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Radical prostatectomy versus observation for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Applying economic evaluation to public health interventions: the case of interventions to promote physical activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Applying health economics for policy decision making: do devices differ from drugs?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

What treatment for early‐stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

The RTOG Outcomes Model: economic end points and measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Assessing the cost-effectiveness of postmastectomy radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175431

6 July 2018

A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in high-risk postmenopausal breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Cost-effectiveness of preoperative radiotherapy in rectal cancer: results from the Swedish Rectal Cancer Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Is Proton Beam Therapy Cost Effective in the Treatment of Adenocarcinoma of the Prostate?

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Implications of spillover effects within the family for medical cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)

1 reference

https://api.crossref.org/works/10.1007%2FS40258-014-0115-8

21 January 2018

Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of two methods for estimating the technical costs of external beam radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic consequence of local control with radiotherapy: cost analysis of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spanish recommendations on economic evaluation of health technologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of intensity-modulated radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton therapy of cancer: potential clinical advantages and cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/25060829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40258-014-0115-8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25060829%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34245541&oldid=2261685354"